Takuya Tsujino

18PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisMolecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 17, 2026
A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.

|May 20, 2026
Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan.

|Mar 31, 2026
A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

Koichiro Kurokawa, Satoshi Yamamoto, Yasutaka Yamada

|Mar 15, 2026
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy.

Takeshi Tsutsumi, Shogo Yamazaki, Takuya Matsuda

|Jan 14, 2026
Translational Advances in Urothelial Carcinoma: From Bench to Bedside.

Tomohiro Iwasawa, Takuya Tsujino, Shigehiro Tsukahara

|Jul 27, 2025
Prognostic Impact of Initial Prostate-Specific Antigen in Metastatic Hormone-Sensitive Prostate Cancer Patients With Extensive Bone Metastases Under Androgen Receptor Signaling Inhibitor.

Saizo Fujimoto, Tsuyoshi Morita, Yutaka Yamamoto

Pageof 3

Frequent Collaborators

7 joint publications

Kazumasa Komura

5 joint publications

Kohei Taniguchi

4 joint publications

Fumihiko Urabe

4 joint publications

Takahiro Kimura